Terms: = Prostate cancer AND FBXW7, AGO, 55294, ENSG00000109670, FLJ11071, SEL-10, CDC4, FBXW6, SEL10, FBW7, DKFZp686F23254, FBX30 AND Prognosis
29 results:
1. Blood Oxylipin Profiles as Markers of Oncological Diseases.
Chistyakov DV; Kovalenko LV; Donnikov MY; Sergeeva MG
Biochemistry (Mosc); 2023 May; 88(5):621-629. PubMed ID: 37331708
[TBL] [Abstract] [Full Text] [Related]
2. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
[TBL] [Abstract] [Full Text] [Related]
3. Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation.
Sun J; Huangfu Z; Yang J; Wang G; Hu K; Gao M; Zhong Z
Adv Drug Deliv Rev; 2022 Nov; 190():114538. PubMed ID: 36162696
[TBL] [Abstract] [Full Text] [Related]
4. Circular noncoding RNA circMBOAT2 is a novel tumor marker and regulates proliferation/migration by sponging miR-519d-3p in colorectal cancer.
Tang X; Sun G; He Q; Wang C; Shi J; Gao L; Ye J; Liang Y; Qu H
Cell Death Dis; 2020 Aug; 11(8):625. PubMed ID: 32796815
[TBL] [Abstract] [Full Text] [Related]
5. [Grading of prostate cancer. For a more precise prognosis].
Algaba F
Rev Esp Patol; 2020; 53(1):19-26. PubMed ID: 31932005
[TBL] [Abstract] [Full Text] [Related]
6. Stromal osseous metaplasia in urothelial carcinoma of the bladder: a rare case report and literature review.
Razafimahefa J; Gosset C; Mongiat-Artus P; Andriamampionona TF; Verine J
Diagn Pathol; 2019 Jul; 14(1):75. PubMed ID: 31299983
[TBL] [Abstract] [Full Text] [Related]
7. Radiogenomics: bridging imaging and genomics.
Bodalal Z; Trebeschi S; Nguyen-Kim TDL; Schats W; Beets-Tan R
Abdom Radiol (NY); 2019 Jun; 44(6):1960-1984. PubMed ID: 31049614
[TBL] [Abstract] [Full Text] [Related]
8. Prostatic Adenocarcinoma: A Grading from Gleason to the New Grade-Group System: A Historical and Critical Review.
Barakzai MA
Asian Pac J Cancer Prev; 2019 Mar; 20(3):661-666. PubMed ID: 30909661
[TBL] [Abstract] [Full Text] [Related]
9. Gleason Score Correlation Between prostate Needle Biopsy and Radical prostatectomy Materials.
Yeldir N; Yildiz E; Dündar G
Turk Patoloji Derg; 2019; 35(3):185-192. PubMed ID: 30859516
[TBL] [Abstract] [Full Text] [Related]
10. Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual.
Wang YQ; Lv JW; Tang LL; Du XJ; Chen L; Li WF; Liu X; Guo Y; Lin AH; Mao YP; Sun Y; Chen YP; Ma J
Oral Oncol; 2019 Mar; 90():23-29. PubMed ID: 30846172
[TBL] [Abstract] [Full Text] [Related]
11. Dancing from bottoms up - Roles of the POZ-ZF transcription factor Kaiso in cancer.
Pierre CC; Hercules SM; Yates C; Daniel JM
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):64-74. PubMed ID: 30419310
[TBL] [Abstract] [Full Text] [Related]
12. Role of RNF20 in cancer development and progression - a comprehensive review.
Sethi G; Shanmugam MK; Arfuso F; Kumar AP
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29934362
[TBL] [Abstract] [Full Text] [Related]
13. Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions.
Sanguedolce F; Cormio A; Musci G; Troiano F; Carrieri G; Bufo P; Cormio L
Crit Rev Clin Lab Sci; 2017 Aug; 54(5):309-325. PubMed ID: 28828885
[TBL] [Abstract] [Full Text] [Related]
14. Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a prostate cancer Patient Cohort with Longitudinal Biological Outcomes.
Alves de Inda M; van Strijp D; den Biezen-Timmermans E; van Brussel A; Wrobel J; van Zon H; Vos P; Baillie GS; Tennstedt P; Schlomm T; Houslay MD; Bangma C; Hoffmann R
Eur Urol Focus; 2018 Apr; 4(3):376-384. PubMed ID: 28753810
[TBL] [Abstract] [Full Text] [Related]
15. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
[TBL] [Abstract] [Full Text] [Related]
16. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
[TBL] [Abstract] [Full Text] [Related]
17. Metastatic cardiac tumor from urothelial carcinoma detected by transthoracic echocardiography: a case report.
Nakashima Y; Tanioka K; Kubo T; Yamasaki N; Yamasaki I; Syuin T; Kitaoka H
J Med Case Rep; 2015 Nov; 9():257. PubMed ID: 26567955
[TBL] [Abstract] [Full Text] [Related]
18. [Role of tissue markers on diagnosis, prognosis and monitoring of prostate cancer].
Mora MJ
Arch Esp Urol; 2015 Apr; 68(3):250-66. PubMed ID: 25948798
[TBL] [Abstract] [Full Text] [Related]
19. Gleason 6 prostate cancer: Translating Biology into Population Health.
Eggener SE; Badani K; Barocas DA; Barrisford GW; Cheng JS; Chin AI; Corcoran A; Epstein JI; George AK; Gupta GN; Hayn MH; Kauffman EC; Lane B; Liss MA; Mirza M; Morgan TM; Moses K; Nepple KG; Preston MA; Rais-Bahrami S; Resnick MJ; Siddiqui MM; Silberstein J; Singer EA; Sonn GA; Sprenkle P; Stratton KL; Taylor J; Tomaszewski J; Tollefson M; Vickers A; White WM; Lowrance WT
J Urol; 2015 Sep; 194(3):626-34. PubMed ID: 25849602
[TBL] [Abstract] [Full Text] [Related]
20. Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?
Bonkhoff H; Wheeler TM; van der Kwast TH; Magi-Galluzzi C; Montironi R; Cohen RJ
Prostate; 2013 Mar; 73(4):442-8. PubMed ID: 22949099
[TBL] [Abstract] [Full Text] [Related]
[Next]
